Resultados de la búsqueda 191-200 of 14006 for total t3

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... complete response (CR) or partial response (PR) and receive WVSCI as compared to whole ventricular radiation on ACNS1123. Colorectal Cancer Screening In ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Furthermore, to determine if open surgical resection is superior to thoracoscopy for event free survival (EFS), for overall survival (OS), and if ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    All participants will undergo baseline screening for evidence of pre-stroke dementia. Those who pass baseline screening will complete a blood draw and a series ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  6. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  7. Neurología - Ensayos clínicos - Mayo Clinic

    All participants will undergo baseline screening for evidence of pre-stroke dementia. Those who pass baseline screening will complete a blood draw and a series ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    All participants will undergo baseline screening for evidence of pre-stroke dementia. Those who pass baseline screening will complete a blood draw and a series ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    All participants will undergo baseline screening for evidence of pre-stroke dementia. Those who pass baseline screening will complete a blood draw and a series ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...